Personalized medicine offers the potential to significantly improve health care by tailoring therapies to the specific needs of patients. However, it also causes changes in the economic and market landscape. The volume of scientific publications and a proven emphasis on genetic testing, health information management, biomarker discovery, and targeted medicines show that personalized medicine research and innovation are extensive and expanding. The market for molecular diagnostics is continuously expanding and diversifying. To overcome these challenges, short-term tactics to deploy programs that are simple and provide clear solutions, as well as long-term strategies to achieve systemic and cultural change, will likely be required.
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece